Drug Development in Wartime: Driving Tomorrow's R&D Decisions.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 30
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2020 AND VI 29 AND IP 6
Results: 15
1
2
How to Keep Home Healthcare on Target: Aligning approaches in quality, control, and oversight to get the most out of including home visits in clinical trial protocols.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 28
- By:
- Publication type:
- Article
3
Busting Patient Recruitment Bottlenecks in Oncology Trials: How integrated data platforms can help find the best-suited patients for cancer studies and reduce the burden on care teams.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 24
- By:
- Publication type:
- Article
4
COVID Challenges for Trials in Low-to-Middle-Income Countries: Outlining the five critical hurdles faced by clinical teams conducting studies in these nations amid quarantine and other restrictions.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 20
- By:
- Publication type:
- Article
5
COVID-Sparked Practices Driving New Patient-Centric Behaviors: Clinical trial stakeholders weigh in on the major shifts unfolding in the era of COVID-19, as efforts move away from the traditional site-based model.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 14
- By:
- Publication type:
- Article
6
USE OF TELEVISITS IN STUDIES AND RELATED PV CONCERNS.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 13
- Publication type:
- Article
7
TAKING STOCK OF INTENTIONAL DOSE NON-ADHERENCE: AI presents rare opportunity to assess the scope of this longtime challenge.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 12
- By:
- Publication type:
- Article
8
EXPLORING UPDATE TO FDA'S PATIENT-FOCUSED DRUG DEVELOPMENT GUIDANCE.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 10
- By:
- Publication type:
- Article
9
COVID-19 PATIENT-TRIAL CONNECTION SITE LAUNCHED.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 9
- Publication type:
- Article
10
SAVE SITES NOW TO PRESERVE THE FUTURE OF CLINICAL TRIALS.
- Published in:
- 2020
- Publication type:
- Interview
11
MONEY AND GOODWILL, BUT WHAT HAPPENS NOW ON COVID THERAPIES?
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 6
- By:
- Publication type:
- Article
12
GERMANY'S HTA AGENCY SEEKS SUPPORT ON TRANSPARENCY ABOUT COVID-19 AGENTS.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 5
- By:
- Publication type:
- Article
13
FDA LEADERSHIP SHIFTS TO ADVANCE COVID DRUGS.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 4
- Publication type:
- Article
14
COVID VACCINE TRIALS REQUIRE FAST DECISIONS, BUT NO SHORTCUTS.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 4
- By:
- Publication type:
- Article
15
A Crisis of Health and Scientific Literacy.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 6, p. 2
- By:
- Publication type:
- Article